Opus Genetics Inc
(IRD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2004 | 03-2004 | 12-2003 | 09-2003 | 06-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,414 | -26 | -160 | -177 | -139 |
| Depreciation Amortization | -14 | 1 | 3 | 2 | 2 |
| Other Working Capital | -107 | 19 | 30 | -30 | -3 |
| Other Operating Activity | 2,162 | 18 | 27 | 56 | 20 |
| Operating Cash Flow | $627 | $11 | $-100 | $-149 | $-121 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -90 | N/A | -8 | -8 | -8 |
| Purchase Of Investment | N/A | -21 | -65 | -30 | -24 |
| Sale Of Investment | N/A | 12 | 20 | 20 | N/A |
| Other Investing Activity | 0 | 0 | -6 | 0 | 0 |
| Investing Cash Flow | $-90 | $-10 | $-60 | $-18 | $-31 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 150 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | -5 | -40 | -46 | -40 |
| Financing Cash Flow | $150 | $-5 | $-40 | $-46 | $-40 |
| Beginning Cash Position | 2,016 | 17 | 230 | 234 | 234 |
| End Cash Position | 2,704 | 13 | 10 | 21 | 42 |
| Net Cash Flow | $688 | $-4 | $-210 | $-213 | $-192 |
| Free Cash Flow | |||||
| Operating Cash Flow | 627 | 11 | -100 | -149 | -121 |
| Capital Expenditure | -90 | N/A | -8 | -8 | -8 |
| Free Cash Flow | 538 | 11 | -108 | -157 | -129 |